How Long Do the Effects of NAD IV Therapy Last?

Is NAD+ IV Therapy Right For You?
Energized man riding a bike in nature, representing the boost in energy, focus, and cellular vitality that NAD+ IV therapy may provide.

NAD⁺ (nicotinamide adenine dinucleotide) IV therapy has become popular for its potential to boost energy, focus, and cellular repair. But one of the most common questions people ask before trying it is: how long does NAD IV actually last?

Research on NAD⁺ infusions is still developing, but a few human studies have looked at what happens to NAD⁺ levels in the body after an IV drip — and how quickly they change. Here’s what current science says about the duration of benefits, what affects them, and how to make results last longer.

What to Expect Right After NAD IV Therapy

Most people report feeling more energized, clear-headed, or focused right after their NAD IV session. This lines up with how NAD⁺ works in the body — it’s a molecule that helps power every cell’s energy production.

In a small clinical study published in Frontiers in Aging Neuroscience (Grant et al., 2019), researchers found that during a 6-hour NAD⁺ infusion, NAD⁺ levels in the blood rose steadily, peaking by the end of the session. These biochemical changes happen quickly, which may explain the almost immediate sense of alertness or energy some people experience after treatment.

However, those elevated NAD⁺ levels in the bloodstream started to decline within a few hours after the drip stopped — suggesting the biological “boost” happens fast and tapers quickly.

How Long Do NAD IV Effects Typically Last?

Here’s where research gives us an honest answer: we don’t yet have large, long-term clinical trials measuring exactly how long people feel the effects of NAD IV therapy.

That said, based on the available data:

  • Blood NAD⁺ levels peak during infusion and begin to normalize within hours after treatment (Grant et al., 2019).

  • Subjective effects — like improved energy, focus, or reduced fatigue — appear to last anywhere from a few days to about two weeks, according to patient feedback in early pilot reports and clinical practice observations.

In other words, the biological boost happens immediately, but how long you feel the benefits can vary depending on individual factors like health, metabolism, and stress levels.

What Factors Affect Duration?

Several factors influence how long NAD⁺ IV therapy feels effective:

  • Dosage and frequency: Higher doses or multiple infusions over a few days may sustain benefits longer. The 2019 clinical study used a 750 mg dose over 6 hours.

  • Metabolism: People metabolize NAD⁺ at different rates, influenced by age, genetics, and cellular enzyme activity (especially enzymes like CD38 and PARPs that use up NAD⁺).

  • Lifestyle: Poor sleep, chronic stress, alcohol use, and poor diet can deplete NAD⁺ more quickly.

  • Overall health: People with chronic fatigue or metabolic issues may feel a shorter or longer duration of benefit depending on their baseline energy and mitochondrial function.

  • Follow-up care: Combining IV therapy with NAD⁺-boosting supplements (like nicotinamide riboside, studied in Nature Communications, 2018) or healthy habits may help maintain NAD⁺ levels longer between treatments.

How to Tell When It’s Wearing Off

NAD⁺ doesn’t “crash” out of your system suddenly, but you may start noticing gradual changes when the effects fade. Common signs include:

  • Fatigue or lower energy levels

  • Mild brain fog or less mental clarity

  • Reduced motivation or mood

  • Slower recovery after physical or mental stress

These are all signals your body’s NAD⁺ levels are returning to their baseline state.

How to Make the Results Last Longer

While the direct effects of NAD⁺ IV therapy fade within hours to days, you can extend the benefits through supportive habits that keep NAD⁺ levels stable:

  1. Stay hydrated – NAD⁺ metabolism depends on proper fluid balance.

  2. Eat nutrient-rich foods – especially those containing vitamin B3 (niacin), tryptophan, and antioxidants.

  3. Get regular exercise – movement improves mitochondrial efficiency and natural NAD⁺ production.

  4. Sleep well – most NAD⁺-dependent repair processes happen overnight.

  5. Limit alcohol and stress – both are known to deplete NAD⁺ stores faster.

  6. Consider oral NAD⁺ precursors – supplements like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) have been shown in human studies to raise NAD⁺ levels over days to weeks (Martens et al., 2018; Airhart et al., 2017).

When to Schedule Your Next Session

Since everyone’s metabolism and goals are different, there’s no one-size-fits-all schedule. Based on current research and clinical practice patterns:

  • For short-term energy or focus: Some people repeat NAD⁺ IVs every 1–2 weeks.

  • For maintenance and cellular health: Monthly sessions or occasional “booster” infusions may be enough, especially if supported with oral precursors and lifestyle changes.

  • For therapeutic goals (like chronic fatigue): Doctors may recommend an initial loading phase — several infusions in the first few weeks — followed by maintenance sessions.

Because the science is still developing, the best approach is to track how long you personally feel benefits and work with your provider to tailor a timeline that fits your needs.

Key Takeaway

Human research shows that NAD⁺ levels rise rapidly during an IV infusion and start to decline within hours afterward. The perceived effects — like energy, focus, or mood — tend to last anywhere from a few days up to about two weeks, depending on your health, habits, and infusion frequency.

Right now, no clinical trial has proven an exact duration of benefit after NAD⁺ IV therapy. But with consistent self-care and proper follow-up, many people find the experience restorative and worth maintaining.

At Heally, we connect patients with licensed clinicians who can guide you through NAD+ therapy safely and effectively. Schedule a free consultation today to explore whether NAD+ IV therapy is right for you.

Sources

  1. Grant R, Berg J, Mestayer R, et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD⁺ Metabolome During a 6-Hour Intravenous Infusion of NAD⁺. Front Aging Neurosci. 2019;11:257. Frontiers
  2. Martens CR, Denman BA, Mazzo M, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD⁺ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. Nature
  3. Airhart SE, Shireman LM, Risler LJ, et al. An open-label, non-randomized study of the pharmacokinetics of nicotinamide riboside in healthy subjects. PLoS One. 2017;12(12):e0186459. PubMed Central
  4. Radenkovic D, Brenner C, et al. Clinical Evidence for Targeting NAD Therapeutically. Pharmaceutics. 2020;13(9):247. (review summarizing human/animal data and gaps). MDPI
  5. (Early IV precursor RCT / pilot) — recent pilot randomized IV study comparing NR IV vs NAD IV (safety/pharmacokinetics) — preprint/pilot data uploaded 2024. This work reports PK/tolerability measures and short follow-up but not long-term efficacy windows. MedRxiv

Medical Disclaimer

This content is for educational purposes only and should not be taken as medical advice, diagnosis, or treatment recommendation. Information about prescriptions and therapies is provided for general understanding and may not apply to individual situations. Always consult a qualified healthcare provider before making decisions about testing, treatment, or lifestyle changes that could affect your health.

Important Note

FDA-approved medications and diagnostic tools discussed in this article have specific indications, dosing, and monitoring requirements. Off-label uses or unregulated supplements may carry additional safety, quality, and effectiveness risks. Never start, stop, or change any medical regimen without guidance from a licensed clinician who can consider your full medical history and current health status.

 

Interested in alternative treatment options? Check out our different services.
Interested in Learning More? Book Free Consultation.
Is NAD+ Nasal Spray Right For You?
0 Shares: